Form 4: BioLife Solutions EVP Aby J. Mathew Sells Shares to Cover Tax Obligations

Aby J. Mathew, EVP & Chief Scientific Officer of BioLife Solutions Inc., sold 425 shares of common stock on March 3, 2025, to cover tax withholding obligations related to vesting restricted stock.

Summary

• On March 3, 2025, Aby J. Mathew, the EVP & Chief Scientific Officer of BioLife Solutions Inc. (BLFS), sold 425 shares of common stock.
• The shares were sold at a price of $25.46 per share.
• The transaction was executed under a pre-arranged Rule 10b5-1(c) trading plan adopted on February 24, 2022.
• The purpose of the sale was to satisfy tax withholding obligations associated with the vesting of restricted stock.
• Following the transaction, Mathew directly owns 262,198 shares of BioLife Solutions Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The sale is part of a pre-planned strategy to cover tax obligations and doesn't necessarily reflect a negative outlook on the company.

Industry Context

Sales by company executives are a normal part of corporate governance. It is important to note that the sale was executed under a pre-arranged 10b5-1 trading plan, which is a common practice to avoid accusations of insider trading.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but the pre-planned nature of the transaction mitigates potential concerns.

Key Dates